dr-dionysis-papadatos-pastos

Dr Dionysis Papadatos-Pastos

24 reviews
 

Reviews

 
Recommend
Trust
Listening
 
« 1 2 3 4 5 »
Page 2 of 5
 
Written by a NHS patient at University College Hospital
4th July 2024


Dr Dionysis Papadatos-Pastos is exactly the doctor and the person one wants to meet as a recently diagnosed mesothelioma patient. He is highly qualified, very experienced, kind and sympathetic. He has a twinkle in his eye. In explaining the options for treatment, and answering questions about these, he is admirably clear. He is also, as the leading oncologist treating mesothelioma at UCH, a centre of excellence at the forefront of cancer research, in a strong position to offer effective treatment and realistic hope for the future to mesothelioma patients. He is on top of his job and seldom keeps patients waiting -- he sees patients, where he can, before their appointment time. He clearly takes an interest in each patient. Being diagnosed with mesothelioma is deeply shocking and frightening. I have, however, found both senior and junior staff at UCL kind, supportive, knowledgeable and positive. Dr Dio exemplifies all these qualities. Lucy Sheppard

Recommend
Trust
Listening
 
Written by a NHS patient at Princess Alexandra Hospital
27th June 2024


Taken very good care of me over the last 2 years, clear information given and always has had time for me.

Recommend
Trust
Listening
 
Written by a NHS patient at Princess Alexandra Hospital
25th June 2024


Having had brain surgery to remove a tumour, which was only partially successful, I was referred to The Princess Alexandra Hospital for further treatment under Dr. Papadatos. At this extremely worrying time Dr. Papadatos put me at ease with his warm, caring and compassionate nature. He listened to my worries, my questions and anxieties, and, explained truthfully and clearly about the treatment I was to have, what side effects etc I should expect and I felt a great confidence in him. The treatment by the nurses and staff in the chemotherapy unit could not be faulted and, on the whole, I consider it, and my continued treatment, second to none.

Recommend
Trust
Listening
 
Written by a NHS patient at University College Hospital
22nd June 2024


Dr Papadatos-Pastos is an excellent doctor. I found him very open, caring, gentle and warm. He made me feel positive and hopeful. Apart from being a skilled oncologist he made a great impact on me. Under his treatment I am doing very well. I wish him all the best.

Recommend
Trust
Listening
 
Written by a NHS patient at University College Hospital
19th June 2024


Very competent and great doctor so glad and lucky that he is my doctor very good listener and understanding . I highly recommend him.

Recommend
Trust
Listening
 
 

« 1 2 3 4 5 »
Page 2 of 5

Profile

Dr Dionysis Papadatos-Pastos is a consultant medical oncologist in London. He is the lead for lung cancer in the CRUK UCL Clinical Trials Centre and the joint lead for oncology at The Princess Alexandra NHS Hospital.

He specialises in the treatment of lung cancer, mesothelioma, and thymoma. Throughout his career, he has gained extensive experience in cancer management using treatments such as immunotherapy, targeted therapies, and chemotherapy.

He graduated in medicine from the University of Athens with distinction, which was followed by his PhD in medical oncology in 2012 with First Class honours. He trained in medical oncology at The Royal Marsden, St George’s University Hospitals, and Guy’s and St Thomas’. He was awarded a diploma in medical oncology from the Institute of Cancer Research at the University of London.

Dr Papadatos-Pastos is an avid researcher and has been the principal investigator on multiple academic and commercial clinical trials. He has also presented at conferences, nationally and worldwide. His topics of research include the development of novel targeted therapies for the treatment of lung cancer, and assessing combinations of immunotherapy drugs with other anti-cancer compounds. Furthermore, he has been widely published in scientific medical journals and peer-reviewed papers.